Anti-Cardiolipin (aCL) Assays

Anti-Cardiolipin (aCL) Assays

Overview

EIA test for the semi-quantitative detection of anti-cardiolipin antibodies in human serum or plasma for determining the presence of Anti-Phospholipid Syndrome (APS)
Read full description

Description

Description

Anti-Cardiolipin (aCL) Assays are intended for the semi-quantitative determination of aCL antibodies in human serum or plasma. Anti-cardiolipin antibodies are frequently found in patients with systemic lupus erythematosus (SLE). Elevated levels of aCL antibodies have been significantly associated with the presence of both venous and arterial thrombosis, thrombocytopenia, and recurrent pregnancy loss.

All Bio-Rad Anti-Cardiolipin (aCL) Assays feature common protocols and common reagents. Reagents and reagent bottle caps are color-coded for ease of use. Test operation is further streamlined with breakaway wells, easy automation, a linear calibration curve and flexible single-point and multi-point calibration options. Quality controls are built in, with undiluted test controls and calibrators.

Assay Characteristics

  • Sample dilution: 1:50
  • Incubation time: 30/30/30 minutes
  • Incubation temperature: room temperature (18–26°C)
  • Conjugate: HRP
  • Substrate: TMB

Documents

Documents

Number Description Options
Q-730
Anti-Cardiolipin Product Sheet
[ Add to Cart (Free) ]